W2. An international perspective focusing on similarities and differences related to substance use disorders in Australia, England, Portugal and the United States
October 29, 2020 2020-10-29 18:11W2. An international perspective focusing on similarities and differences related to substance use disorders in Australia, England, Portugal and the United States
An international perspective focusing on similarities and differences related to substance use disorders in Australia, UK, Portugal and USA
Live session: Friday, October 30th 2020
Additional pre-recorded materials
1. Historical Perspectives
2. Access to Care
3. Impact of COVID-19
To be released soon
Abstract
According to the World Drug Report (2018) the scope of drugs and drug markets are increasing and spreading globally. The international community needs to step up its responses to cope with these challenges. Members of IntNSA, representing Australia, England, Portugal, and the United States, will come together to share their experience of the similarities and differences between their countries that impact on the successes/failures related to substance use disorders. Topics covered will include historical perspectives, access to care, harm reduction approaches, treatment modalities, impact of COVID 19, among others. As this workshop will be online topics will be divided into ‘learning units’ of 1.5 hours in duration. An opportunity for participants to take “comfort breaks” of 30 mins in between each unit of learning will be provided.
Learning objectives
- Participants will be able to identify the historical perspective of each country and understand how history impacts treatment of substance use disorders today (1.5 hrs) (12:00 EST)
- Participants will be able to describe and learn different concepts and practices of access to treatment for substance use disorders (1.5 hrs) (2:00 pm EST)
- Participants will be able to define harm reduction and learn different concepts and meaning in the practice of harm reduction (1.5 hrs) (4:00pm EST
- Participants will be able to identify at least one current and future trends in treatment of substance use disorders in the identified countries. (1.5 hrs) (6:00pm EST)
- Participants will describe how COVID-19 has impacted the care and practice of those with substance use disorders (1.5hrs) (8:00pm EST)
Facilitators
- Dana Murphy-Parker
MS, APRN, PMHNP-BC, CARN-AP, FIAAN, USA - Theresa Fay-Hillier
DrPH, MSN, PMHCNS-BC, USA - Roseann Regan
PhD, APRN, BC, USA - Adrian Jugdoyal
PGDip, PGCAP, BSc (Hons), PGCertHE, RGN, RMN, NMP, TCH, FHEA, UK - Adam Searby
PhD, RN, Australia - Paulo Rosario De Carvalho Seabra
PhD, MSN, BSN, Portugal
Join the workshop
days
hours
minutes
seconds
Click here to join
If the button above doesn’t work, you can log in by clicking here, or by entering the Meeting ID and password:
Meeting ID: 882 7816 4407
Password: 674386